A

Agilent
NYSE

Real-time Quotes | Nasdaq Last Sale

130.11
-1.04
-0.79%
After Hours: 130.90 +0.79 +0.61% 17:36 05/17 EDT
OPEN
130.84
PREV CLOSE
131.15
HIGH
131.05
LOW
129.91
VOLUME
886.73K
TURNOVER
--
52 WEEK HIGH
137.83
52 WEEK LOW
80.46
MARKET CAP
39.64B
P/E (TTM)
49.94
1D
5D
1M
3M
1Y
5Y
Pershing Square confirms Domino's stake, Starbucks exit, adds to HHC stake
As Bill Ackman had already announced last week, Pershing Square Capital Management swapped in a Domino's Pizza (DPZ) stake for its Starbucks (SBUX) holding, the firm's latest 13F filing confirms.Holds
Seekingalpha · 1h ago
Agilent Technologies Inc. stock outperforms competitors despite losses on the day
Shares of Agilent Technologies Inc. slumped 0.79% to $130.11 Monday, on what proved to be an all-around poor trading session for the stock market, with the...
marketwatch.com · 1h ago
Fox Run Management, L.l.c. Buys JPMorgan Chase, PNC Financial Services Group Inc, ...
GuruFocus News · 4h ago
The 'new momentum' stocks to watch: Alpha Tactics
In the stock market, momentum tends to perform best in this stage of the recovery cycle, while "new momentum" has further room to run, UBS says.UBS strategist Keith Parker defines
Seekingalpha · 1d ago
Skandinaviska Enskilda Banken AB (publ) Buys Bristol-Myers Squibb Company, Weyerhaeuser Co, The ...
GuruFocus News · 3d ago
Winslow Capital Management, LLC Buys Starbucks Corp, Hilton Worldwide Holdings Inc, Edwards ...
GuruFocus News · 4d ago
Will Baidu's (BIDU) Q1 Earnings Benefit From iQIYI Momentum?
Baidu's (BIDU) first-quarter results are expected to reflect a solid momentum across iQIYI's content portfolio.
Zacks · 4d ago
Lumentum (LITE) Q3 Earnings & Revenues Lag Estimates
Zacks.com · 4d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of A. Analyze the recent business situations of Agilent through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 20 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average A stock price target is 140.23 with a high estimate of 150.00 and a low estimate of 126.00.
EPS
Institutional Holdings
Institutions: 1.14K
Institutional Holdings: 298.53M
% Owned: 97.98%
Shares Outstanding: 304.70M
TypeInstitutionsShares
Increased
231
7.88M
New
67
2.04M
Decreased
238
8.43M
Sold Out
36
1.16M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-0.90%
Healthcare Equipment & Supplies
-0.70%
Key Executives
Non-Executive Chairman/Independent Director
Boon Hwee Koh
President/Chief Executive Officer/Director
Michael McMullen
Chief Financial Officer/Senior Vice President
Robert McMahon
Senior Vice President/General Counsel/Secretary
Michael Tang
Senior Vice President/Director of Human Resources
Dominique Grau
Senior Vice President
Henrik Ancher-Jensen
Senior Vice President
Padraig McDonnell
Senior Vice President
Samraat Raha
Senior Vice President
Jacob Thaysen
Chief Accounting Officer/Vice President/Controller
Rodney Gonsalves
Vice President
Allison Ballmer
Other
Katharine Knobil
Independent Director
Mala Anand
Independent Director
Hans Bishop
Independent Director
Paul Clark
Independent Director
Heidi Kunz
Independent Director
Daniel Podolsky
Independent Director
Sue Rataj
Independent Director
Susan Rataj
Independent Director
George Scangos
Independent Director
Dow Wilson
Declaration Date
Dividend Per Share
Ex-Div Date
03/17/2021
Dividend USD 0.194
04/05/2021
11/18/2020
Dividend USD 0.194
01/04/2021
09/16/2020
Dividend USD 0.18
10/05/2020
05/20/2020
Dividend USD 0.18
06/29/2020
03/18/2020
Dividend USD 0.18
03/30/2020
11/20/2019
Dividend USD 0.18
12/30/2019
09/18/2019
Dividend USD 0.164
09/30/2019
05/22/2019
Dividend USD 0.164
07/01/2019
03/20/2019
Dividend USD 0.164
04/01/2019
11/14/2018
Dividend USD 0.164
12/28/2018
09/19/2018
Dividend USD 0.149
10/01/2018
05/16/2018
Dividend USD 0.149
07/02/2018
03/21/2018
Dividend USD 0.149
04/02/2018
11/15/2017
Dividend USD 0.149
12/29/2017
09/20/2017
Dividend USD 0.132
10/02/2017
05/18/2017
Dividend USD 0.132
06/29/2017
03/16/2017
Dividend USD 0.132
03/31/2017
11/18/2016
Dividend USD 0.132
12/29/2016
09/22/2016
Dividend USD 0.115
09/30/2016
05/19/2016
Dividend USD 0.115
06/30/2016
03/17/2016
Dividend USD 0.115
04/01/2016
11/20/2015
Dividend USD 0.115
12/31/2015
09/17/2015
Dividend USD 0.1
09/25/2015
05/21/2015
Dividend USD 0.1
06/26/2015
03/19/2015
Dividend USD 0.1
03/27/2015
11/21/2014
Dividend USD 0.1
01/02/2015
09/18/2014
Dividend USD 0.132
09/26/2014
05/22/2014
Dividend USD 0.132
06/27/2014
04/01/2014
Dividend USD 0.132
04/09/2014
11/22/2013
Dividend USD 0.132
12/27/2013
09/19/2013
Dividend USD 0.12
09/27/2013
05/23/2013
Dividend USD 0.12
06/28/2013
About A
Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business. Its life sciences and applied markets business segment offers instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. Its diagnostics and genomics business segment includes the reagent partnership, pathology, companion diagnostics, genomics and the nucleic acid solutions businesses. Its Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio.

Webull offers kinds of Agilent Technologies Inc stock information, including NYSE:A real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, A stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading A stock methods without spending real money on the virtual paper trading platform.